Cargando…
Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity
Asymptomatic individuals, called “silent spreaders” spread SARS-CoV-2 efficiently and have complicated control of the ongoing COVID-19 pandemic. As seen in previous influenza pandemics, socioeconomic and life-trajectory factors are important in disease progression and outcome. The demographics of th...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157140/ https://www.ncbi.nlm.nih.gov/pubmed/34067606 http://dx.doi.org/10.3390/jcm10102159 |
_version_ | 1783699614434590720 |
---|---|
author | Holuka, Cyrielle Snoeck, Chantal J. Mériaux, Sophie B. Ollert, Markus Krüger, Rejko Turner, Jonathan D. |
author_facet | Holuka, Cyrielle Snoeck, Chantal J. Mériaux, Sophie B. Ollert, Markus Krüger, Rejko Turner, Jonathan D. |
author_sort | Holuka, Cyrielle |
collection | PubMed |
description | Asymptomatic individuals, called “silent spreaders” spread SARS-CoV-2 efficiently and have complicated control of the ongoing COVID-19 pandemic. As seen in previous influenza pandemics, socioeconomic and life-trajectory factors are important in disease progression and outcome. The demographics of the asymptomatic SARS-CoV-2 carriers are unknown. We used the CON-VINCE cohort of healthy, asymptomatic, and oligosymptomatic individuals that is statistically representative of the overall population of Luxembourg for age, gender, and residency to characterise this population. Gender (male), not smoking, and exposure to early-life or adult traumatic experiences increased the risk of IgA seropositivity, and the risk associated with early-life exposure was a dose-dependent metric, while some other known comorbidities of active COVID-19 do not impact it. As prior exposure to adversity is associated with negative psychobiological reactions to external stressors, we recorded psychological wellbeing during the study period. Exposure to traumatic events or concurrent autoimmune or rheumatic disease were associated with a worse evolution of anxiety and depressive symptoms throughout the lockdown period. The unique demographic profile of the “silent spreaders” highlights the role that the early-life period plays in determining our lifelong health trajectory and provides evidence that the developmental origins of health and disease is applicable to infectious diseases. |
format | Online Article Text |
id | pubmed-8157140 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81571402021-05-28 Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity Holuka, Cyrielle Snoeck, Chantal J. Mériaux, Sophie B. Ollert, Markus Krüger, Rejko Turner, Jonathan D. J Clin Med Article Asymptomatic individuals, called “silent spreaders” spread SARS-CoV-2 efficiently and have complicated control of the ongoing COVID-19 pandemic. As seen in previous influenza pandemics, socioeconomic and life-trajectory factors are important in disease progression and outcome. The demographics of the asymptomatic SARS-CoV-2 carriers are unknown. We used the CON-VINCE cohort of healthy, asymptomatic, and oligosymptomatic individuals that is statistically representative of the overall population of Luxembourg for age, gender, and residency to characterise this population. Gender (male), not smoking, and exposure to early-life or adult traumatic experiences increased the risk of IgA seropositivity, and the risk associated with early-life exposure was a dose-dependent metric, while some other known comorbidities of active COVID-19 do not impact it. As prior exposure to adversity is associated with negative psychobiological reactions to external stressors, we recorded psychological wellbeing during the study period. Exposure to traumatic events or concurrent autoimmune or rheumatic disease were associated with a worse evolution of anxiety and depressive symptoms throughout the lockdown period. The unique demographic profile of the “silent spreaders” highlights the role that the early-life period plays in determining our lifelong health trajectory and provides evidence that the developmental origins of health and disease is applicable to infectious diseases. MDPI 2021-05-17 /pmc/articles/PMC8157140/ /pubmed/34067606 http://dx.doi.org/10.3390/jcm10102159 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Holuka, Cyrielle Snoeck, Chantal J. Mériaux, Sophie B. Ollert, Markus Krüger, Rejko Turner, Jonathan D. Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity |
title | Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity |
title_full | Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity |
title_fullStr | Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity |
title_full_unstemmed | Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity |
title_short | Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity |
title_sort | adverse life trajectories are a risk factor for sars-cov-2 iga seropositivity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157140/ https://www.ncbi.nlm.nih.gov/pubmed/34067606 http://dx.doi.org/10.3390/jcm10102159 |
work_keys_str_mv | AT holukacyrielle adverselifetrajectoriesareariskfactorforsarscov2igaseropositivity AT snoeckchantalj adverselifetrajectoriesareariskfactorforsarscov2igaseropositivity AT meriauxsophieb adverselifetrajectoriesareariskfactorforsarscov2igaseropositivity AT ollertmarkus adverselifetrajectoriesareariskfactorforsarscov2igaseropositivity AT krugerrejko adverselifetrajectoriesareariskfactorforsarscov2igaseropositivity AT turnerjonathand adverselifetrajectoriesareariskfactorforsarscov2igaseropositivity AT adverselifetrajectoriesareariskfactorforsarscov2igaseropositivity |